Notification That Quarterly Report Will Be Submitted Late (nt 10-q)
May 14 2018 - 4:32PM
Edgar (US Regulatory)
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
FORM 12b-25
Commission File Number
000-53500
NOTIFICATION OF LATE FILING
(Check One):
¨
Form
10-K
¨
Form 11-K
¨
Form
20-F
x
Form 10-Q
¨
Form
N-SAR
For
Period Ended: March 31, 2018
¨
Transition Report on Form 10-K
|
¨
Transition Report on Form 10-Q
|
¨
Transition Report on Form 20-F
|
¨
Transition Report on Form N-SAR
|
¨
Transition Report on Form 11-K
|
|
For
the Transition Period Ended:
Read
Attached Instruction Sheet Before Preparing Form. Please Print or Type.
Nothing
in this form shall be construed to imply that the Commission has verified any information contained herein.
If the notification relates to a portion of the filing checked
above, identify the Item(s) to which the notification relates:
Part I-Registrant Information
Full Name of Registrant
|
Creative Medical Technology Holdings, Inc.
|
|
|
Former Name if Applicable
|
|
|
|
Address of principal executive office
|
2017 W Peoria Ave
|
|
|
City, State and Zip Code
|
Phoenix, Arizona 85029
|
Part II-Rules 12b-25 (b) and (c)
If the subject report could not be filed
without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed.
(Check box if appropriate)
x
|
a.
|
The reasons described in reasonable detail in Part
III of this form could not be eliminated without unreasonable effort or expense;
|
|
b.
|
The subject annual report, semi-annual report, transition
report on Form 10-K, 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or before the fifteenth calendar day following
the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof will be filed on
or before the fifth calendar day following the prescribed due date; and
|
|
c.
|
The accountant’s statement or other exhibit required
by Rule 12b-25(c) has been attached if applicable.
|
Part III-Narrative
State below in reasonable detail the reasons
why the form 10-K, 11-K, 20-F, 10-Q or N-SAR, or the transition report or portion thereof could not be filed within the prescribed
time period. (Attach extra sheets of needed.)
The Company has been unable to complete
the review process with the auditor.
Part IV-Other Information
|
1.
|
Name and telephone number of person to contact in regard
to this notification
|
Timothy Warbington
|
(833)
|
336-7636
|
(Name)
|
(Area Code)
|
(Telephone No.)
|
|
2.
|
Have all other periodic reports required under section
13 or 15(d) of the Securities Exchange Act of 1934 or section 30 of the Investment Company Act of 1940 during the preceding 12
months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify
report(s).
|
x
Yes
¨
No
|
3.
|
Is it anticipated that any significant change in results
of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included
in the subject report or portion thereof?
|
¨
Yes
x
No
If so, attach an explanation of the anticipated change,
both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results
cannot be made.
Creative
Medical Technology Holdings, Inc.
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the
undersigned thereunto duly authorized.
Date: May 14, 2018
|
By:
|
/s/ Donald Dickerson
|
|
|
Donald Dickerson
, Chief Financial Officer
|